海外の治験の状況「濾胞性リンパ腫」での検索結果
1540件の検索結果
- 進捗状況
- 試験名
- 対象疾患名
- 国名
- 登録日
Not recruiting
- Non-Interventional Study to Examine Rituximab Treatment in Follicular Lymphoma Participants
- Follicular Lymphoma;Follicular Lymphoma;Follicular Lymphoma;Follicular Lymphoma
- Germany
- 2015-08-24
Not Recruiting
- A study to identify the most effective dose of Betalutin in patients with a type of follicular lymphoma that is CD37-positive which has recurred
- Relapsed CD37+ non-Hodgkin B-cell follicular lymphoma br>MedDRA version: 18.0 Level: PT Classification code 10029547 Term: Non-Hodgkin's lymphoma System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) MedDRA version: 18.0 Level: PT Classification code 10003902 Term: B-cell lymphoma recurrent System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) ;Therapeutic area: Diseases [C] - Blood and lymphatic diseases [C15]
- Austria, Belgium, Canada, Czech Republic, Denmark, France, Germany, Hungary, Israel, Italy, Netherlands, Norway, Poland, Russian Federation, Spain, Sweden, Turkey, United Kingdom, United States
- 2015-07-07
Not Recruiting
- Subjects with previously untreated Follicular Lymphoma will be treated with a combination of the study drug IPI-145 and Rituximab or Obinutuzumab
- Follicular Lymphoma br>MedDRA version: 18.1 Level: LLT Classification code 10025311 Term: Lymphoma (non-Hodgkin's) System Organ Class: 100000004864 ;Therapeutic area: Diseases [C] - Cancer [C04]
- Belgium, France, Italy, Spain, United Kingdom, United States
- 2015-06-10
Not recruiting
- Rituximab Therapy in Follicular Lymphoma in Combination With Chemotherapy - REFLECT 1
- Follicular Lymphoma;Follicular Lymphoma;Follicular Lymphoma;Follicular Lymphoma
- Serbia
- 2015-05-29
Not recruiting
- A Study of Rituximab in Combination With Chemotherapy in Relapsed/Refractory Follicular Lymphoma
- Lymphoma, Follicular;Lymphoma, Follicular;Lymphoma, Follicular;Lymphoma, Follicular
- Serbia
- 2015-05-28
Recruiting
- A study comparing PF-05280586 to MabThera® (rituximab) in patients with follicular lymphoma who have not received previous treatment.
- CD20-positive, low tumor burden, Follicular Lymphoma
- Austria, Belarus, Belgium, Brazil, Canada, Croatia, Egypt, France, Germany, Greece, India, Italy, Japan, Lebanon, Mexico, Other, Peru, Philippines, Poland, Portugal, Republic of Korea, Romania, Russian Federation, South Africa, Spain, Switzerland, Thailand, Turkey, Ukraine, United Kingdom, United States of America
- 2015-05-26
Not recruiting
- Study of Rituximab Plus Pembrolizumab (MK-3475) in Subjects With Relapsed Follicular Lymphoma
- Lymphoma
- United States
- 2015-05-13
Recruiting
- Efficacy of Consolidative Involved-site Radiotherapy for Patients With Limited-stage Follicular Lymphoma
- Follicular Lymphoma
- China
- 2015-05-07
Recruiting
- Efficacy of Palliative Low-Dose Involved-Field Radiation Therapy for Recurrent Advanced Follicular Lymphoma
- Recurrent Follicular Lymphoma
- China
- 2015-04-27
Not recruiting
- A Study of Duvelisib in Combination With Rituximab or Obinutuzumab in Subjects With Previously Untreated CD20+ Follicular Lymphoma (CONTEMPO)
- CD20+ Follicular Lymphoma
- Belgium, France, Italy, Spain, United Kingdom, United States
- 2015-03-03
